Recent Quotes
My Watchlist
Indicators
Local Stocks
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mid Cap SPDR 400 Trust, Series 1 (NY: MDY )

586.13 -6.53 (-1.10%)
Official Closing Price Updated: 8:00 PM EST, Nov 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Mid Cap SPDR 400 Trust, Series 1

Commvault Continues its Rally, Outpacing Tech Stocks, Midcaps
Commvault Systems has seen a 22.49% stock-price rise since January 30th, with investors increasingly bullish on the data-recovery specialist's prospects. 
Via MarketBeat
Topics ETFs
Wendy's Walks Back Surge Pricing Talk After Social Media Grilling
Wendy's stock climbed after the company backed away from surge pricing after social media backlash. Revenue is slowing, but Wall Street sees upside. 
Via MarketBeat
Beyond Nvidia: The hidden stars with 200% earnings growth
It's rare for a company like Nvidia to achieve 200% earnings growth. Smaller stocks Fluor, Jefferies and Golden Entertainment also show explosive EPS growth. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Chesapeake to buy Southwestern Energy as natural gas prices rise
Chesapeake and Southwestern's $7.4 billion merger aims to address the growing global demand for natural gas; the companies expect a 20% dividend increase 
Via MarketBeat
Topics Energy
Exposures Fossil Fuels
Celsius stock in actionable zone as big investors ramp up buying
Celsius gained momentum in the last trading days of 2023 after a November pullback. Celsius' growth is fueled by strong revenue and support from backer PepsiCo. 
Via MarketBeat
Topics Initial Public Offering
Exposures Securities Market
Is Super Micro Computer an Unsung Hero of AI-Driven Growth?
Super Micro Computer's latest earnings report highlights its strength in AI infrastructure. The company anticipates strong growth in fiscal year 2024 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Does Ciena's Earnings Beat Signal New Networking Boom Ahead?
Network gear maker Ciena saw a sizeable gap-up in stock price after strong Q3 earnings. What does that say about prospects for the broader industry? 
Via MarketBeat
Topics Artificial Intelligence Earnings
Exposures Artificial Intelligence Financial
Don't Overlook Hidden Gem Kinsale As Rallies To New Highs
Kinsale Capital Group beat Wall Street views, spurring price outperformance relative to other insurers and its mid-cap index. Institutions are buying shares. 
Via MarketBeat
Emcor Stock in Buy Zone As it Rebounds Off 50-Day Average
Emcor Group shows strong buying support as it bounces off its 50-day average. The stock is outperforming its index as earnings growth accelerates. 
Via MarketBeat
Topics ETFs
Shockwave Medical, Fast Grower, In Boston Scientific's Sights?
Shockwave earnings are growing at triple-digit rates. The company easily beat Q1 views. Boston Scientific is reportedly interested in acquiring Shockwave. 
Via MarketBeat
Topics ETFs
Analysts Have "Buy" Rating On This Mid-Cap Dividend Achiever
Mid-cap industrial-sector stock Donaldson is a steady gainer, returning 32.44% in the past year. It has a 36-year track record of increasing its dividend. 
Via MarketBeat
Texas Roadhouse: Analysts Boost Price Targets Despite EPS Miss
Texas Roadhouse found support at its 50-day average after missing Q1 earnings views. The company reiterated expectations for sales growth this year. 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Is Mid-Cap Hubbell The Right Stock To Electrify Your Portfolio?
Hubbell stock is trading at new highs following better-than-expected Q1 results. Wall Street sees the company growing earnings by 27% this year. 
Via MarketBeat
Topics ETFs Supply Chain
Exposures Supply Chain
Cabot Boosting Production In Lithium Battery Chain For EV Market
Chemical maker Cabot is growing to meet demand for materials to produce lithium-ion batteries. It may offer a buy opportunity on a moving-average pullback. 
Via MarketBeat
Topics ETFs
Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
Neurocrine Biosciences trended higher with the broad market Thursday, coming within a penny of Tuesday’s high of $125.99. It is forming a bullish channel. 
Via MarketBeat
Can Mid-Cap Lantheus Continue its 2022 Outperformance?
Mid-cap Lantheus Holdings has been on a revenue growth spurt boosted by a new product called Pylarify, which helps detect prostate cancer in an imaging test. 
Via MarketBeat
Topics ETFs Initial Public Offering
Exposures Securities Market
3 Stocks With Market-Beating Price Performance
Digi International, Lamb Weston Holdings, and Wingstop traded higher in heavy trading volume,. Mid-caps are outperforming the S&P 500 large-cap index this year. 
Via MarketBeat
Topics ETFs Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.